Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Human Therapeutics Pty. Ltd.

Latest From Human Therapeutics Pty. Ltd.

Caribou brings in $11m for CRISPR tech

Janssen touts Transposagen technology in CAR-T collaboration

Transposagen Biopharmaceuticals doesn't make a big public fuss about its pharmaceutical collaborations – the Lexington, Kentucky-based company has relationships with 19 out of the top 20 big pharma – but the Johnson & Johnson subsidiary Janssen Biotech is happy to tout the promise of its new partner's technology.

Cancer Neurology

BioNotebook: Three new deals, including Calico's first drug license agreement

Calico licenses UT Southwestern compounds from 2M; MabVax gets into CAR T business with MSKCC and Juno; and Kolltan buys Xetrios.

Cancer Neurology

Elan to 'release' $1bn from Tysabri pay-off

Elan will spend $1 billion of the $3.25 billion one-off payment it is receiving from Biogen Idec for the return of rights to the blockbuster multiple sclerosis drug Tysabri to buy back around a 16% stake in the Irish company.

Neurology Immune Disorders
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals